JP2014518508A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518508A5
JP2014518508A5 JP2013558110A JP2013558110A JP2014518508A5 JP 2014518508 A5 JP2014518508 A5 JP 2014518508A5 JP 2013558110 A JP2013558110 A JP 2013558110A JP 2013558110 A JP2013558110 A JP 2013558110A JP 2014518508 A5 JP2014518508 A5 JP 2014518508A5
Authority
JP
Japan
Prior art keywords
decorin
medium
core protein
hydroxyapatite
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558110A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518508A (ja
JP5965927B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/028911 external-priority patent/WO2012125626A2/en
Publication of JP2014518508A publication Critical patent/JP2014518508A/ja
Publication of JP2014518508A5 publication Critical patent/JP2014518508A5/ja
Application granted granted Critical
Publication of JP5965927B2 publication Critical patent/JP5965927B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558110A 2011-03-14 2012-03-13 デコリン組成物およびその使用 Active JP5965927B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161452299P 2011-03-14 2011-03-14
US61/452,299 2011-03-14
PCT/US2012/028911 WO2012125626A2 (en) 2011-03-14 2012-03-13 Decorin compositions and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016082308A Division JP2016185952A (ja) 2011-03-14 2016-04-15 デコリン組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2014518508A JP2014518508A (ja) 2014-07-31
JP2014518508A5 true JP2014518508A5 (enExample) 2014-09-11
JP5965927B2 JP5965927B2 (ja) 2016-08-10

Family

ID=46828968

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013558110A Active JP5965927B2 (ja) 2011-03-14 2012-03-13 デコリン組成物およびその使用
JP2016082308A Pending JP2016185952A (ja) 2011-03-14 2016-04-15 デコリン組成物およびその使用
JP2018146607A Active JP6831813B2 (ja) 2011-03-14 2018-08-03 デコリン組成物およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016082308A Pending JP2016185952A (ja) 2011-03-14 2016-04-15 デコリン組成物およびその使用
JP2018146607A Active JP6831813B2 (ja) 2011-03-14 2018-08-03 デコリン組成物およびその使用

Country Status (6)

Country Link
US (2) US20120238727A1 (enExample)
EP (2) EP2686335B1 (enExample)
JP (3) JP5965927B2 (enExample)
CN (1) CN103917655B (enExample)
DK (1) DK2686335T3 (enExample)
WO (1) WO2012125626A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2907944C (en) * 2013-04-22 2020-11-03 Catalent Pharma Solutions, Llc Veterinary decorin compositions and use thereof
EP3001838A4 (en) 2013-05-14 2017-02-08 Medlmmune, LLC Synthetic oligosaccharide subunits of the psl exopolysaccharide of pseudomonas aeruginosa and uses therof
JP2018048053A (ja) 2016-09-23 2018-03-29 昭和電工株式会社 SiC単結晶成長用坩堝
US11377488B2 (en) * 2018-07-03 2022-07-05 Catalent Pharma Solutions, Llc Multifunctional protein molecules comprising decorin and use thereof
BR112022017718A2 (pt) * 2020-03-05 2022-11-16 Diamedica Usa Inc Polipeptídeos de ulinastatina

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI906411A7 (fi) * 1988-06-28 1990-12-27 La Jolla Cancer Res Foundation Solujen lisääntymisen esto Decorinilla
US5654270A (en) * 1988-06-28 1997-08-05 La Jolla Cancer Research Foundation Use of fibromodulin to prevent or reduce dermal scarring
US6509314B1 (en) * 1988-06-28 2003-01-21 The Burnham Institute Methods of preventing or reducing scarring with decorin or biglycan
WO1993009800A1 (en) * 1991-11-14 1993-05-27 La Jolla Cancer Research Foundation Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
EP0636175A1 (en) * 1992-04-03 1995-02-01 La Jolla Cancer Research Foundation Decorin fragments and methods of inhibiting cell regulatory factors
US5567807A (en) * 1994-07-08 1996-10-22 La Jolla Cancer Research Foundation Processes for the purification of human recombinant decorin and the detection of guanidinium ions
BR0110577A (pt) * 2000-05-05 2003-12-30 Gtc Biotherapeutics Inc Decorina transgenicamente produzida
AU2001271614B2 (en) * 2000-07-03 2007-05-31 Catalent Pharma Solutions, Llc Host cells containing multiple integrating vectors
US20040235173A1 (en) 2000-07-03 2004-11-25 Gala Design, Inc. Production of host cells containing multiple integrating vectors by serial transduction
US20030224415A1 (en) 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
US20030124152A1 (en) * 2001-11-02 2003-07-03 Pang Danny Zhong Der Use of decorin in a cosmetic or dermatologic composition
KR100495126B1 (ko) * 2002-04-16 2005-06-14 한국생명공학연구원 N-아세틸갈락토스아미닐트랜스퍼라제 활성을 갖는 융합 단백질, 이를 코딩하는 유전자 및 상기 유전자가 도입된 형질전환 세포주
ES2496596T3 (es) * 2007-03-23 2014-09-19 Asahi Kasei Pharma Corporation Método para producir trombomodulina soluble de gran pureza
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

Similar Documents

Publication Publication Date Title
RU2596408C2 (ru) Способ очистки человеческого фактора, стимулирующего колонии гранулоцитов, из рекомбинантных е. coli
JP2013500711A5 (enExample)
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
RU2015141849A (ru) Способ очистки фактора свертывания крови viii
AU709584B2 (en) Industrial production process for a vaccine against Japanese encephalitis, and vaccine obtained
ES2552337T3 (es) Procedimientos para la preparación de plasminógeno
JP4250771B2 (ja) カチオン交換クロマトグラフィーによる因子VIII/vWF複合体の精製方法
NO324659B1 (no) Utvinning av von Willebrand-faktor ved kationebytterkromatografi samt preparat inneholdende slik faktor og anvendelse derav.
JP4644604B2 (ja) 2価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
US9868762B2 (en) Method for purifying virus-like particles (VLP)
CN111849945B (zh) 人凝血因子VIIa的纯化方法
CN103571800A (zh) 一种去除疫苗中宿主dna的方法
WO2011116291A1 (en) Production of human c1 inhibitor in human cells
KR100841599B1 (ko) 칼슘 이온-결합 단백질의 정제 방법
WO2002034785A1 (fr) Procede de monomerisation de polymeres d"albumine serique humaine
CN106916803A (zh) 一种双齿围沙蚕纤溶蛋白酶及其制备方法和用途
JP2009536821A5 (enExample)
JP2025509722A5 (enExample)
JP2019163212A (ja) スフェロイド形成促進剤の濃縮方法および精製方法。
CN101143889B (zh) 一种大肠杆菌表达的重组人白介素-11的纯化方法
CN103864916B (zh) 人胸腺肽β4三倍体蛋白、编码基因及其分离纯化方法
CN105755008A (zh) 编码猪α干扰素的DNA分子及其重组蛋白的表达纯化方法
JP4643932B2 (ja) アメロゲニン融合タンパク質
JP4798830B2 (ja) ヒト血清アルブミン多量体の単量体化方法
JPS6226226A (ja) 抗腫瘍性ポリペプチド